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PHYPERTENSION
Variation in Body Composition Determines Long-Term
Blood Pressure Changes in Pre-Hypertension
The MONICA/KORA (Monitoring Trends and Determinants on Cardiovascular
Diseases/Cooperative Research in the Region of Augsburg) Cohort Study
Marcello Ricardo Paulista Markus, MD,*†‡ Jan Stritzke, MD,* Ulrike Siewert, PSYM,§
Wolfgang Lieb, MD,* Andreas Luchner, MD, Angela Döring, MD,¶ Ulrich Keil, MD,†
Hans-Werner Hense, MD,† Heribert Schunkert, MD,* for the MONICA/KORA Investigators
Lübeck, Münster, Greifswald, Regensburg, and Neuherberg, Germany; São Paulo, Brazil
Objectives We studied the relationship between changes in body composition and changes in blood pressure levels.
Background The mechanisms underlying the frequently observed progression from pre-hypertension to hypertension are
poorly understood.
Methods We examined 1,145 subjects from a population-based survey at baseline in 1994/1995 and at follow-up in
2004/2005. First, we studied individuals pre-hypertensive at baseline who, during 10 years of follow-up, either
had normalized blood pressure (PreNorm, n  48), persistently had pre-hypertension (PrePre, n  134), or
showed progression to hypertension (PreHyp, n  183). In parallel, we studied predictors for changes in blood
pressure category in individuals hypertensive at baseline (n  429).
Results After 10 years, the PreHyp group was characterized by a marked increase in body weight (5.71% [95% confi-
dence interval (CI): 4.60% to 6.83%]) that was largely the result of an increase in fat mass (17.8% [95% CI:
14.5% to 21.0%]). In the PrePre group, both the increases in body weight (1.95% [95% CI: 0.68% to 3.22%])
and fat mass (8.09% [95% CI: 4.42% to 11.7%]) were significantly less pronounced than in the PreHyp group
(p  0.001 for both). The PreNorm group showed no significant change in body weight (1.55% [95%
CI: 3.70% to 0.61%]) and fat mass (0.20% [95% CI: 6.13% to 6.52%], p  0.05 for both, vs. the PrePre
group).
Conclusions After 10 years of follow-up, hypertension developed in 50.1% of individuals with pre-hypertension and only
6.76% went from hypertensive to pre-hypertensive blood pressure levels. An increase in body weight and fat
mass was a risk factor for the development of sustained hypertension, whereas a decrease was predictive of a
decrease in blood pressure. (J Am Coll Cardiol 2010;56:65–76) © 2010 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.01.056p
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Mhe definition of normal blood pressure is difficult because
n Western societies, blood pressure tends to increase in
ost individuals during the aging process. For the gray zone
etween clearly normal and undoubtedly elevated blood
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f the German Research Foundation (Deutsche Forschungsgemeinschaft [DFG],
FG Schu 672/12-1), the Federal Ministry of Education and Research
Bundesministerium für Bildung und Forschung [BMBF], NGFN2 [FKZ-
1GS0418, to Dr. Schunkert]), the Competence Network of Heart Failure
BMBF-01GI0205 to Drs. Markus, Hense, and Schunkert) and the University of
übeck Medical School (A39-2005 to Dr. Stritzke). The KORA research
latform and the MONICA study were initiated and financed by the Helmholtz
entrum München, German Research Center for Environmental Health, which
s founded by the Federal Ministry of Education and Research and by the Bavarian
inistry of Finance.
Manuscript received October 8, 2009; revised manuscript received December 21,
009, accepted January 4, 2010.
a
r
a
S
o
P
c
p
m
w
d
l
d
e
i
p
o
w
i
M
S
p
M
f
p
s
p
b
s
1
i
b
f
o
(
F
f
e
l
I
a
a
b
b
s
d
a
p
T
t
N
p
m
p
p
c
a
c
a
g
b
i
h
f
m
C
n
g
c
d
w
d
m
m
l
f
m
v
d
q
i
C
i
S
p
w
i
i
l
66 Markus et al. JACC Vol. 56, No. 1, 2010
Variation in Body Composition in Pre-Hypertension June 29, 2010:65–76it represents 30% of the overall
healthy adult population (2).
However, the condition may her-
ald arterial hypertension. Indeed,
as many as 49.5% of subjects with
pre-hypertension may present
with manifest hypertension within
4 years of follow-up (3–5). The
mechanisms responsible for such
frequently observed progression
from pre-hypertension to hyper-
tension are incompletely under-
stood, but pre-hypertension may
be considered a starting point in
the cardiovascular disease contin-
uum (6).
In cross-sectional samples,
blood pressure levels are associ-
ted with body composition. In particular, there is a positive
elationship between overweight and obesity with the prev-
lence of hypertension. Specifically, the Framingham Heart
tudy found that hypertension is about twice as prevalent in
bese compared with lean individuals (7). Likewise, the
AMELA (Pressioni Arteriose Monitorate E Loro Asso-
iazioni) study showed that total body weight measures
redicted new onset of hypertension (8). Moreover, a recent
eta-analysis concluded that a 1-kg loss of total body
eight was associated with an approximate 1-mm Hg
ecrease in blood pressure (9). Based on these findings,
ifestyle measures have been proposed for individuals to
ecrease the risk of the manifestation of hypertension.
There are few prospective, population-based studies that
xamined factors that specifically modify disease progression
n pre-hypertensive individuals (2,10). In the present
opulation-based study, we investigated the natural history
f pre-hypertension and hypertension over a 10-year period
ith special emphasis on the impact of dynamic variations
n body composition on blood pressure.
ethods
tudy population. The MONICA/KORA Augsburg
roject was part of the international collaborative WHO
ONICA project and investigated the cardiovascular risk
actor profile of randomly selected subjects of the resident
opulation in cross-sectional surveys. The study design,
ampling frame, and data collection were described in detail
reviously (11). Between October 1994 and June 1995,
aseline data were obtained from the third MONICA
urvey (S3) in the city of Augsburg, Germany. A total of
,506 participants, age 25 to 74 years at baseline, were
nvited for a follow-up study (F3) that was conducted
etween March 2004 and May 2005.
A total of 169 individuals were inaccessible or ineligible
or the F3 examination due to death (n  58), interdiction
Abbreviations
and Acronyms
CI  confidence interval
HypHyp  persistently
hypertensive
HypNorm  hypertensive-
normotensive
HypPre  hypertensive-
pre-hypertensive
OR  odds ratio
PreHyp  pre-hypertensive-
hypertensive
PreNorm  pre-
hypertensive-normotensive
PrePre  persistently pre-
hypertensivef recontact (people that refused to be contacted again) dn  63), having moved (n  41), and severe illness (n  7).
rom the remaining individuals, 1,152 participated in the
ollow-up study (net response: 76.5%) of whom 7 (0.61%) were
xcluded because of lack of information about blood pressure
evels.
nterview and medical examination. On both occasions,
ll participants underwent an interview related to personal
nd family medical history, lifestyle and nutrition, health
ehavior, and psychosocial factors. Body height and total
ody weight were measured in light clothing. Blood pres-
ure values were corrected for differences of observers and
evices between the 2 examinations (see the Statistical
nalysis section). The mean of the second and third blood
ressure measurements was used for the present analyses.
he blood pressure categories were defined on the basis of
he criteria of the Joint National Committee 7 report (1).
ormal blood pressure was defined as a systolic blood
ressure 120 mm Hg and a diastolic blood pressure 80
m Hg. Pre-hypertension was defined as a systolic blood
ressure of 120 to 139 mm Hg and/or a diastolic blood
ressure of 80 to 89 mm Hg. Arterial hypertension was
onsidered as a systolic blood pressure of 140 mm Hg
nd/or a diastolic blood pressure of 90 mm Hg or
urrently taking antihypertensive medication. If the systolic
nd diastolic pressure readings belonged to different cate-
ories, the higher of the 2 readings was used to assign the
lood pressure category. Body mass index was defined as the
ndividual’s total body weight divided by the square of its
eight. Fat mass was calculated as total body weight minus
at-free mass. Fat-free mass was determined by measure-
ent of bioelectrical impedance analysis with the Body
omposition Analyzer TVI-10 (Danziger Medical Tech-
ology, Heidelberg, Germany), as previously reported in
reater detail (12). The percentage of fat-free mass was
alculated as absolute fat-free mass multiplied by 100 and
ivided by total body weight. The percentage of fat mass
as calculated as absolute fat mass multiplied by 100 and
ivided by total body weight. Waist circumference was
easured at the level of the navel. Hip circumference was
easured at its widest part. The waist-hip ratio was calcu-
ated as the waist circumference divided by the hip circum-
erence. In addition, participants underwent standardized
edical examinations including collection of nonfasting
enous blood samples. Diabetes mellitus was defined as
isease known to the patient, as reported by standard
uestionnaire, the use of antiglycemic oral medications or
nsulin, or nonfasting glucose blood levels of 200 mg/dl.
ardiovascular disease was defined as stroke or myocardial
nfarction reported by standard questionnaire.
tudy groups. From the 1,145 subjects for whom blood
ressure was measured in both examinations 10 years apart,
e extracted 2 baseline groups that were then subdivided
nto 3 subgroups each. The first group consisted of partic-
pants who presented with pre-hypertensive blood pressure
evels (120 to 139 mm Hg systolic or 80 to 89 mm Hg
iastolic blood pressure, without medication: 365 individu-
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June 29, 2010:65–76 Variation in Body Composition in Pre-Hypertensionls) and the second group consisted of participants who
resented with hypertensive blood pressure levels (139
m Hg systolic or 89 mm Hg diastolic or taking
ntihypertensive medication: 429 individuals) in the base-
ine examination. The baseline pre-hypertensive group was
hen subdivided. The first subgroup consisted of partici-
ants who presented with pre-hypertensive blood pres-
ure levels in the baseline and with normal blood pres-
ure levels (120 mm Hg systolic blood pressure and
80 mm Hg diastolic blood pressure, no medication) in the
ollow-up examination (n  48), which we called the
re-hypertensive-normotensive (PreNorm) group. The sec-
nd subgroup consisted of individuals who presented with
re-hypertensive blood pressure levels in the baseline study
nd again with pre-hypertensive blood pressure levels in the
ollow-up study (n  134), which we called the persistently
re-hypertensive (PrePre) group. The third group consisted
f individuals who presented with pre-hypertensive blood
ressure levels in the baseline study and with hypertensive
lood pressure levels (139 mm Hg systolic or 89 mm
g diastolic or taking antihypertensive medication) at the
ollow-up examination (n  183), which we called the
re-hypertensive-hypertensive (PreHyp) group. The base-
ine hypertensive group had also 3 subgroups. The first
ubgroup consisted of participants who presented with
ypertensive blood pressure levels in the baseline study and
ith normal blood pressure levels at the follow-up exami-
ation (n  8), which we called the hypertensive-
ormotensive (HypNorm) group. The second subgroup
onsisted of individuals who presented with hypertensive
lood pressure levels in the baseline study and with pre-
ypertensive blood pressure levels in the follow-up study
n  29), which we called the hypertensive-pre-hypertensive
HypPre) group. Finally, the third subgroup consisted of
ndividuals who presented with hypertensive blood pressure
evels in the baseline and again with hypertensive blood
ressure levels at the follow-up examination (n  392), which
e called the persistently hypertensive (HypHyp) group. The
ypNorm subgroup was excluded from further analyses be-
ause of the small number of individuals in this group (n 8).
tatistical analysis. Blood pressure measurements were
erformed with different measurement devices in S3 and F3,
eflecting technological progress. Systematic differences be-
ween surveys due to different measurement methods were
ssessed by using data from a sample of 1,005 individuals
xamined on both occasions using a mixed regression
odel, as described in more detail previously (13).
The groups were compared with regard to their crude
haracteristics at baseline and follow-up using frequencies,
ean values, and SDs. Statistical significances were tested
ith t tests for the mean values for continuous variables and
hi-square tests for categorical variables. Adjusted mean
alues and the 95% confidence interval (CI) in the cross-
ectional analysis of baseline and follow-up measurements
ere calculated with multivariate linear regression models that included age, sex, body mass index, and systolic blood
ressure at the baseline study. For prospective analyses, the
djusted relative changes in the variables of interest, that is,
(value F3  value S3)/value S3], were calculated in each
roup and expressed as percentages. To account for regres-
ion to the mean effects in the variable for which the
ross-sectional analysis of the follow-up and the relative
hanges were studied, we additionally adjusted for the
verall baseline mean of the variable of interest. Odds ratios
ORs) for the cumulative risk of incident hypertension and
he possibility of incident normalization of blood pressure
evels, comparing quartiles and a 5% increase and decrease
f relative changes in variables of total body weight and
omposition, were calculated with a logistic regression
odel that included age, sex, body mass index, and systolic
lood pressure at baseline and the overall baseline mean of
he variable of interest. All analyses were performed using
PSS version 15.0.0 for Windows (SPSS Inc., Chicago,
llinois).
esults
linical and laboratory characteristics. BASELINE Pre-Hyp
ROUP. The prevalence of pre-hypertension at the baseline
tudy was 31.9% (365 of 1,145 study subjects with 10-year
ollow-up). We identified 204 (55.9%) men and 161
44.1%) women with pre-hypertension. After 10 years of
ollow-up, blood pressure values normalized in 48 (13.2%)
ndividuals, 134 (36.7%) had persistent pre-hypertension,
nd hypertension developed in 183 (50.1%). One individual
2.08%) in the PreNorm group, 3 (2.27%) in the PrePre
roup, and 17 (9.29%) in the PreHyp group developed
ardiovascular disease (stroke or myocardial infarction, p for
rend  0.016). The PreNorm group included 1 (2.13%),
he PrePre 6 (4.51%) and the PreHyp 19 (10.4%) individ-
als with incident or prevalent diabetes mellitus at the
ollow-up study (p for trend  0.049). Finally, 17 (35.4%)
ndividuals in the PreNorm group, 34 (25.6%) in the PrePre
roup, and 27 (14.8%) in the PreHyp group were smokers
p for trend  0.018).
The anthropometric characteristics of the baseline pre-
ypertensive group are contained in Table 1. Almost two-
hirds of subjects in the PreNorm group were women.
ther differences, at baseline, between the 3 groups were
ound with respect to age, blood pressure, and glycosylated
emoglobin.
In pre-hypertensive individuals in whom hypertension
ubsequently developed, baseline nonadjusted body mass
ndex, fat mass, percentage of fat mass, waist circumfer-
nce, and waist-hip ratio were already higher, whereas
he percentage fat-free mass was lower than in those who
emained pre-hypertensive. No statistical difference was
een for total body weight and absolute fat-free mass
Table 1).
ASELINE HYPERTENSIVE GROUP. The prevalence of hyper-
ension at the baseline study was 37.5% (429 of 1,145 study
68 Markus et al. JACC Vol. 56, No. 1, 2010
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Table 1
Cr d Anthropometric and L bora or Charact ristics of the PreNorm, PrePre, and
PreHyp Individuals at Baseline (1994/1995) and at the Follow-Up Examination
(2004/2005) of the MONICA/KORA Cohort Study
Characteristic PreNorm PrePre PreHyp p Value
Men (%) 19 (39.6) 85 (63.4) 100 (54.6)
Women (%) 29 (60.4) 49 (36.6) 83 (45.4) 0.015
Age at baseline (yrs) 40.5 13.3 43.8 11.9 52.7 11.2 0.001
Height at baseline (cm) 169.1 8.10 171.5 9.36 168.4 9.17 0.012
BMI (kg/m2)
1994/1995 25.3 3.59 25.9 3.66 26.9 3.47 0.004
2004/2005 25.4 3.64 26.6 3.64 28.1 3.87 0.001
TBW (kg)
1994/1995 72.4 11.1 76.2 12.5 76.6 12.6 NS
2004/2005 72.7 11.8 78.2 12.7 79.8 13.6 0.004
FFM (kg)
1994/1995 51.0 8.17 54.5 9.25 52.5 9.65 NS
2004/2005 50.9 8.48 54.9 9.70 53.1 10.0 0.042
FFM (%)
1994/1995 71.0 8.03 71.9 7.91 68.6 6.98 0.001
2004/2005 69.9 8.15 70.4 7.68 66.4 7.24 0.001
Fat mass (kg)
1994/1995 21.3 7.74 21.6 8.08 24.2 6.87 0.004
2004/2005 22.3 8.02 23.4 7.78 27.0 7.74 0.001
Fat mass (%)
1994/1995 29.0 8.03 28.1 7.91 31.4 6.98 0.001
2004/2005 30.1 8.15 29.6 7.68 33.6 7.24 0.001
WC (cm)
1994/1995 81.8 10.4 87.9 10.9 89.9 10.8 0.001
2004/2005 87.1 11.4 94.0 11.1 97.4 11.4 0.001
WHR
1994/1995 0.81 0.08 0.86 0.08 0.87 0.08 0.001
2004/2005 0.84 0.08 0.89 0.07 0.91 0.08 0.001
SBP (mm Hg)
1994/1995 119.8 8.33 123.1 8.36 126.1 7.29 0.001
2004/2005 109.6 7.07 128.2 6.60 142.7 19.8 0.001
DBP (mm Hg)
1994/1995 80.2 6.36 80.0 6.52 81.7 5.64 0.033
2004/2005 72.9 4.00 80.8 5.53 86.8 10.4 0.001
Total cholesterol (mg/dl)
1994/1995 226.0 38.3 227.9 41.5 236.6 43.6 NS
2004/2005 214.3 40.9 220.3 35.2 220.6 42.5 NS
LDL cholesterol (mg/dl)
1994/1995 134.2 41.9 139.0 42.3 146.3 42.0 NS
2004/2005 128.4 37.7 130.4 30.0 127.3 33.9 NS
HDL cholesterol (mg/dl)
1994/1995 60.4 20.5 53.9 16.0 54.3 15.6 0.049
2004/2005 57.6 15.4 57.6 15.4 57.3 16.2 NS
HbA1c (%)
1994/1995 5.14 0.42 5.03 0.45 5.26 0.92 0.030
2004/2005 5.18 0.22 5.19 0.30 5.36 0.46 0.001
Total (%) 48 (13.2) 134 (36.7) 183 (50.1)
Values are presented as mean  SD. p values are given for the comparison among the pre-hypertensive-normotensive (PreNorm), persistently
pre-hypertensive (PrePre), and pre-hypertensive-hypertensive (PreHyp) individuals at the baseline (1994/1995) and the follow-up examination
(2004/2005) of the MONICA-KORA cohort study.BMI body mass index; DBP diastolic blood pressure; FFM fat-free mass; HbA1c glycosylated hemoglobin; SBP systolic blood pressure;
TBW  total body weight; WC  waist circumference; WHR  waist-hip ratio.
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Abbreviations as in Table 1.
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June 29, 2010:65–76 Variation in Body Composition in Pre-Hypertensionubjects with 10-year follow-up). We identified 236 (55.0%)
en and 193 (45.0%) women with hypertension. After 10
ears of follow-up, 8 (1.86%) individuals had normalized
lood pressure values, 29 (6.76%) had pre-hypertension, and
92 (91.4%) individuals had persistent hypertension. The
ndividuals from the HypNorm group were, from this point,
xcluded from further analyses because of their small num-
er. Cardiovascular disease developed in none of the indi-
iduals in the HypPre group, but did in 34 (8.81%) in the
ypHyp group (stroke or myocardial infarction, p  NS).
he HypPre group included 1 (3.57%) and the HypHyp 58
14.9%) individuals with incident or prevalent diabetes
ellitus at the follow-up study (p NS). Finally, 3 (10.3%)
ndividuals in the HypPre group and 48 (12.2%) in the
ypHyp group were smokers (p  NS).
The characteristics of the hypertensive group at baseline
re shown in Table 2. More than two thirds of subjects in
hom blood pressure levels decreased to pre-hypertension
ere men. Again, there were other differences at baseline
uch as age and blood pressure between subjects who
emained hypertensive and those who became pre-
ypertensive. In hypertensive individuals who subsequently
emained hypertensive, the baseline nonadjusted absolute
at mass value and the percentage of fat mass were already
igher, whereas the absolute fat-free mass value and per-
entage of fat-free mass were lower compared with the
ypPre group. No statistical difference was seen for body
ass index, total body weight, waist circumference, and
aist-hip ratio (Table 2).
ynamic changes in body measures and composition.
ASELINE PRE-HYPERTENSIVE GROUP. At follow-up, pre-
ypertensive subjects who became hypertensive (i.e., the
reHyp group) presented a more pronounced increase in
otal body weight, waist circumference, and waist-hip ratio
ompared with the other 2 pre-hypertensive groups (Fig.
A). The increase in these parameters in individuals in the
rePre group was moderate and significantly less pro-
ounced than in the PreHyp group. The PreNorm group
ad the lowest values in each category. Likewise, when the
lterations in body measures were expressed as a percentage
f change from baseline values, the PreHyp group showed
he most prominent dynamic changes in total body weight
nd the other variables (Fig. 1A).
The most prominent change in body composition was
bserved in terms of a marked increase in fat mass in
ubjects in the PreHyp group (Fig. 1B). By contrast,
hanges in absolute fat-free mass were less prominent, and
here was even a marked decrease in the percentage of
at-free mass. The group with normalized blood pressure
evels had only a small increase in the absolute and percent-
ge of fat mass and a decrease in the absolute and percentage
f fat-free mass. Consequently, there were significant dif-
erences in dynamic changes in body composition overtime
etween the PreNorm and the PreHyp groups, whereas the
rePre group was at an intermediary level (Fig. 1B).rude Anthropometric and Laboratoryharacteristics of he HypPre and H pHypndividuals at the Baseli e (1994/1995) and theollow-Up Examina ion (2004/2005) of theONIC /KORA Coh rt Study
Table 2
Crude Anthropometric and Laboratory
Characteristics of the HypPre and HypHyp
Individuals at the Baseline (1994/1995) and the
Follow-Up Examination (2004/2005) of the
MONICA/KORA Cohort Study
Characteristic HypPre HypHyp p Value
Men (%) 21 (72.4) 211 (53.8)
Women (%) 8 (27.6) 181 (46.2) NS
Age at baseline (yrs) 45.8 14.2 56.1 10.8 0.001
Height at baseline (cm) 172.1 8.69 167.2 9.08 0.004
BMI (kg/m2)
1994/1995 27.1 3.60 28.4 3.87 NS
2004/2005 26.7 3.55 28.8 4.34 0.011
TBW (kg)
1994/1995 80.3 11.5 79.3 12.8 NS
2004/2005 79.2 12.2 80.7 14.5 NS
FFM (kg)
1994/1995 56.5 8.71 52.4 9.48 0.026
2004/2005 56.3 9.14 52.4 10.1 0.049
FFM (%)
1994/1995 70.7 7.50 66.2 7.05 0.001
2004/2005 71.5 7.70 65.1 7.21 0.001
Fat mass (kg)
1994/1995 23.8 7.50 27.0 7.73 0.029
2004/2005 22.8 7.47 28.4 8.61 0.001
Fat mass (%)
1994/1995 29.3 7.50 33.8 7.05 0.001
2004/2005 28.5 7.70 34.9 7.21 0.001
WC (cm)
1994/1995 91.2 9.03 93.7 10.9 NS
2004/2005 94.7 10.2 100.0 11.7 0.017
WHR
1994/1995 0.88 0.07 0.89 0.08 NS
2004/2005 0.90 0.08 0.92 0.08 NS
SBP (mm Hg)
1994/1995 132.5 10.2 144.1 17.1 0.001
2004/2005 128.7 6.31 144.4 21.5 0.001
DBP (mm Hg)
1994/1995 90.3 5.22 90.3 11.3 NS
2004/2005 83.2 4.61 86.5 12.8 NS
Total cholesterol (mg/dl)
1994/1995 238.7 47.7 240.3 39.4 NS
2004/2005 227.3 47.0 220.6 40.5 NS
LDL cholesterol (mg/dl)
1994/1995 143.8 48.0 151.5 40.2 NS
2004/2005 134.5 37.9 128.9 32.8 NS
HDL cholesterol (mg/dl)
1994/1995 55.4 19.5 51.7 14.3 NS
2004/2005 58.9 19.1 54.2 15.3 NS
HbA1c (%)
1994/1995 5.07 0.43 5.37 0.88 NS
2004/2005 5.26 0.27 5.48 0.55 0.035
Total (%) 29 (6.89) 392 (93.1)
alues are presented as mean  SD. p values are given for the comparison of the hypertensive-
re-hypertensive (HypPre) and hypertensive-hypertensive (HypHyp) individuals at the baseline
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Variation in Body Composition in Pre-Hypertension June 29, 2010:65–76ASELINE HYPERTENSIVE GROUP. At follow-up, subjects
n the HypHyp group had significantly higher values in
otal body weight, waist circumference, and waist-hip
atio compared with the HypPre group (Fig. 2A). Im-
ortantly, over the 10-year period, the HypPre group was
haracterized by a marked decrease in total body weight
nd smaller increases in waist circumference and waist-
ip ratio (Fig. 2A).
Dynamic changes in body composition were significantly
ifferent in the subjects in the HypPre group compared with
he HypHyp group (Fig. 2B). Over the 10-year period, the
ypPre group was characterized by a marked decrease in
he absolute and percentage of fat mass and the absolute
at-free mass, but not in the percentage of fat-free mass,
hich increased markedly. By contrast, the absolute and
ercentage of fat mass increased in the group who remained
aintained hypertensive with small decreases in the abso-
Figure 1 Baseline Pre-Hypertensive Group Body Measures and
(Left) The mean values and the 95% confidence interval (adjusted for sex, age, bo
body weight, waist circumference (WC), waist-hip ratio (WHR), and for body compo
and percentage of fat-free mass (PFFM) of the pre-hypertensive-normotensive (PreN
Hyp) groups at the baseline (1994 to 1995) and at follow-up examination (2004 to
sex, baseline age, body mass index, and systolic blood pressure plus overall base
PrePre, and PreHyp groups over the 10-year period.ute and percentage of fat-free mass (Fig. 2B). pactors associated with blood pressure category. In pre-
ypertensive subjects, sex had no influence on the incident
R of hypertension (data not shown), but women had
reater chance than men (adjusted for baseline age, body
ass index, and systolic blood pressure) to have normalized
lood pressure levels (OR: 2.18; 95% CI: 1.09 to 4.36).
fter adjustment (for sex, baseline body mass index, and
ystolic blood pressure), age had a strong effect on the
robability of the development of hypertension but no
nfluence on the probability of blood pressure normaliza-
ion. The OR for incident hypertension in the group with
ges between 65 and 74 years was 7.36 (95% CI: 2.66 to
0.3) compared with the group of ages between 25 and 34
ears.
Figure 3 represents parameters of body composition,
ivided in quartiles, that influenced the OR (adjusted for sex
nd baseline age, body mass index, and systolic blood
Composition
ss index, and systolic blood pressure, all at baseline) for body measures (A) of
B) including fat mass (FAT), percentage of fat mass (PFAT), fat-free mass (FFM),
persistently pre-hypertensive (PrePre), and pre-hypertensive-hypertensive (Pre-
). (Right) The relative changes and the 95% confidence interval (adjusted for
ean of the variable under analysis) of the same variables of the PreNorm,Body
dy ma
sition (
orm),
2005
line mressure plus overall baseline mean of the variable of
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June 29, 2010:65–76 Variation in Body Composition in Pre-Hypertensionnterest) for the cumulative risk of incident hypertension
Fig. 3A) and normalization of blood pressure levels (Fig.
B) over the 10-year period. Again, dynamic changes in the
bsolute and percentage of fat mass showed strong effects on
hese developments.
Table 3 shows the OR for an increase of 5% (risk of
ypertension) or a decrease of 5% (normalization of blood
ressure levels) for each parameter of body composition over
he 10-year interval in subjects who were pre-hypertensive
t baseline.
iscussion
he prevalence of pre-hypertension in this population-
Figure 1 Continuedased sample was 31.9% at the baseline study, which is wimilar to previous studies of other populations (14,15).
nother important finding in the present study and previ-
us studies (16,17) is the high rate of progression from
re-hypertension to hypertension (i.e., 50% over a 10-year
eriod). In the PAMELA study (18), in which the risks of
hite-coat or masked hypertension for the development of
ustained hypertension were evaluated; in 60% of patients,
rue hypertension developed from normotension. In the
ccompanying editorial about that study (19), it was empha-
ized that identifying clues to discover patients who are prone
o progress would be a seminal issue. In addition to aging,
early all parameters of body composition analyzed, namely fat
ass, fat-free mass, body weight, waist circumference, and
aist-hip ratio were profoundly related to the subsequent
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uently, the MONICA/KORA Augsburg cohort study pro-
ides such a clue, showing that weight gain is a powerful risk
actor for the development of sustained hypertension.
The prevalence of hypertension at the baseline study was
7.5%. As expected, after 10 years of follow-up, 91.4% of
hese individuals persistently had hypertension. Similarly, in
he PAMELA study (18), just 8% of the subjects reverted
rom true hypertension to normotension. Although the
robability of moving into a lower blood pressure category
as small, any change was again strongly affected by
ynamic changes in body composition.
Beyond age, the most important contributors to the
volution from pre-hypertension to hypertension were dy-
amic weight changes. The effect of obesity on the progres-
ion of hypertension was also reported in the study by Vasan
t al. (3), who assessed in nonhypertensive subjects the
requency of progression to hypertension. In agreement
Figure 2 Baseline Hypertensive Group Body Measures and Bod
(Left) The mean values and the 95% confidence interval (adjusted for sex, age, bo
body weight, WC, and WHR and for body composition (B) including FAT, PFAT, FFM
sive (HypHyp) groups at the baseline (1994 to 1995) and follow-up examination (2
for sex, baseline age, body mass index, and systolic blood pressure plus overall b
HypHyp groups over the 10-year period. Abbreviations as in Figure 1.ith this study, which analyzed the effects of dynamic shanges on total body weight, we observed, in addition, that
ynamic changes in body composition are important deter-
inants of incident hypertension. These findings add to the
ubstantial data linking obesity and weight gain to the future
isk of hypertension (20,21).
In addition to changes in absolute weight, we observed
hat maintenance (rather than increase) of fat mass was
ssociated with a lower likelihood of the progression from
re-hypertension to hypertension. In the group that was
re-hypertensive at baseline and whose blood pressure levels
ecreased (i.e., PreNorm group), we observed even a de-
rease in body weight, which resulted mainly from a
ecrease in fat-free mass. Moreover, individuals hyperten-
ive at baseline whose blood pressure levels decreased (i.e.,
ypPre group) presented a similar pattern, but with a more
ronounced decrease in fat mass that even resulted in an
ncrease in the relative percentage of fat-free mass despite a
ecrease in absolute fat-free mass. Interestingly, obese
position
ss index, and systolic blood pressure, all at baseline) for body measures (A) of
PFFM of the hypertensive-pre-hypertensive (HypPre) and hypertensive-hyperten-
o 2005). (Right) The relative changes and the 95% confidence interval (adjusted
e mean of the variable under analysis) of the same variables of the HypPre andy Com
dy ma
, and
004 t
aselinubjects who underwent gastric surgery showed that in
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June 29, 2010:65–76 Variation in Body Composition in Pre-Hypertensionarallel with a significant and persistent weight loss after
ariatric surgery, blood pressure levels return to pre-surgical
evels after a follow-up of 10 years (22). Thus, although it
as been well established that an increase in weight is a risk
or the development of hypertension, it is not clear what,
ver a prolonged period of time, the effect of a decrease in
eight will have on blood pressure, but drastic changes in
ody composition may be mandatory to reestablish pre-
ypertension once hypertension has been diagnosed, as was
he case in our study.
The majority of subjects in this population-based sample
ained weight over the 10-year period. This dynamic
hange was almost exclusively driven by an increase in fat
Figure 2 Continuedass and linked to progression from pre-hypertension to bypertension. Thus, during aging, fat mass accounts for an
ncreasing proportion of total body weight. If this generally
bserved process is being slowed down or even stopped,
here are increased chances that pre-hypertensive individu-
ls remain in this blood pressure category or even have
ormalized blood pressure.
Although the effects of chronic weight changes in
re-hypertensive individuals are incompletely understood
23), several trials assessed the effect of weight loss on
ypertension. On predominantly hypertensive individu-
ls, a recent meta-analysis of 25 randomized, controlled
rials showed that a weight loss of 1 kg (by means
f energy restriction, increased physical activity, or
oth) was associated with a decrease of 1.05 mm Hg in
s
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plus overall baseline mean of the variable of interest.
Abbreviations as in Table 1.
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Variation in Body Composition in Pre-Hypertension June 29, 2010:65–76ystolic blood pressure and 0.92 mm Hg in diastolic
lood pressure (9). This blood pressure reduction was
ccomplished without the necessity of also attaining
ormal total weight (9,23). The present study extends
hese data to the situation in a population-based sample
ith pre-hypertension and long-term follow-up. Partic-
larly, the data suggest that weight maintenance in
re-hypertensive subjects is important and effective to
ecrease the probability of the development of hyperten-
ion. In individuals with already established hyperten-
ion, the loss in total body weight increases the proba-
ility of a normalization of blood pressure levels. This
nding adds to data from randomized studies that dem-
nstrated the effect of lifestyle modification on blood
ressure and supports the intentions of primary preven-
ion as derived from the Framingham Heart Study (24).
Although changes in fat mass most accurately predicted
Pressure Levels
dy mass index, and systolic blood pressure plus overall baseline mean of the vari-
uals with baseline pre-hypertension, by quartiles (mean  SD) of relative changes in
ve probability of incident normalization of blood pressure levels in individuals withFigure 3 Incident Hypertension and Incident Normalization of Blood
(A) The mean values and the 95% confidence interval of adjusted (for sex, baseline age, bo
able under analysis) odds ratio for 10-year cumulative risk of incident hypertension in individ
FAT, PFAT, FFM, and PFFM. (B) The same values of adjusted odds ratio for 10-year cumulati
baseline pre-hypertension. Abbreviations as in Figure 1.djusted Odds Ratios for 10-Year Cumulativerobability of Incident Hypertension or Inc d ntormal zati n of Bl od Pressure Levels inndividuals With Pr -Hypertension at Baselin
Table 3
Adjusted Odds Ratios for 10-Year Cumulative
Probability of Incident Hypertension or Incident
Normalization of Blood Pressure Levels in
Individuals With Pre-Hypertension at Baseline
Characteristics*
Odds Ratio (95% Confidence Interval)
Risk of Hypertension Normalization
TBW 1.55 (1.31–1.84) 1.60 (1.26–2.05)
WC 1.43 (1.21–1.70) 1.51 (1.19–1.92)
WHR 1.32 (1.0–1.66) 1.40 (1.04–1.90)
FAT 1.15 (1.08–1.22) 1.15 (1.05–1.25)
PFM 1.23 (1.11–1.36) 1.23 (1.07–1.40)
FFM 2.13 (1.49–3.04) 2.19 (1.30–3.68)
PFFM 0.49 (0.36–0.66) 0.53 (0.37–0.78)
dds ratios are shown for an increase of 5% (risk of hypertension) or a decrease of 5%
normalization of blood pressure levels) for each parameter of body composition over the 10-year
nterval of follow-up. *Adjusted for sex, baseline age, body mass index, and systolic blood pressurehanges in the blood pressure category, we were surprised by
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June 29, 2010:65–76 Variation in Body Composition in Pre-Hypertensionhe increase in waist circumference and waist-hip ratio in
he individuals who actually lost weight during 10 years of
ollow-up. As fat mass occupies more space than the same
eight of fat-free mass, the increase in fat mass observed in
he pre-hypertensive group could be the explanation for this
bservation. Thus, it appears that during aging, body
omposition is redistributed, even when the overall weight
tays the same, toward an increase in fat mass and expansion
f the abdominal cavity. This is noteworthy because few
revious observational longitudinal studies analyzed the
ffects of aging and the changes in total body weight and
ody composition on blood pressure levels and waist cir-
umference.
tudy limitations. This study was conducted in white
ubjects, so the results cannot be extended to other ethnic
roups. The necessary adjustment by sex may carry some
imitations, but it was not possible to present the data for
en and women separately because of the small sample size
n some subgroups. The study sample was derived from a
opulation-based sampling frame but loss to follow-up or
omorbid conditions may have introduced some imbalances
n our participants. Blood pressure measurements were
erformed by different methods in the baseline and
ollow-up studies. Systematic differences were estimated
rom specified models and used to derive adequate correc-
ion values. We cannot conceive of any methodological
mbalances arising from these corrections that would lead to
ystematically biased cardiac results among the groups in
his study.
onclusions
e observed in a population-based sample that changes
n body composition are highly predictive of the risk of
rogression from pre-hypertension to hypertension. Most
otably, increases in fat mass resulting in an increase in
aist circumference predicted the onset of hypertension.
Our findings serve to emphasize the importance of
ontrolling the gain in fat mass and thereby central obesity
n the primary prevention of hypertension at the level of the
verall population. There is an urgent need to increase the
wareness among both health professionals and the general
ublic about the health hazards of central or abdominal
besity. This notion is emphasized by the close correlation
f incident hypertension with dynamic changes in fat mass
nd waist circumference. Because the progression rates from
re-hypertension to hypertension increase with age, it ap-
ears important to introduce lifestyle modifications (as
uggested by the Joint National Committee 7 Report [1]) as
arly in adult life as possible. According to Hu (25),
Although maintaining a healthy weight should continue to
e a cornerstone in the prevention of chronic diseases and
remature death, maintaining a healthy waist size should
lso be an important goal.”
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